{"id":1381,"date":"2018-12-10T19:37:13","date_gmt":"2018-12-10T18:37:13","guid":{"rendered":"https:\/\/congresos.sebbm.es\/madrid2019\/?page_id=1381"},"modified":"2019-07-15T10:45:19","modified_gmt":"2019-07-15T08:45:19","slug":"symposia-speakers","status":"publish","type":"page","link":"https:\/\/congresos.sebbm.es\/madrid2019\/program\/symposia-speakers\/","title":{"rendered":"Symposia Speakers"},"content":{"rendered":"

[vc_row][vc_column width=\u00bb1\/2″][vc_column_text]<\/p>\n

Symposia Speakers<\/h1>\n

[\/vc_column_text][vc_empty_space][\/vc_column][vc_column width=\u00bb1\/2″][vc_column_text]<\/p>\n

in collaboration with<\/em><\/p>\n

[\/vc_column_text][vc_single_image image=\u00bb2049″ img_size=\u00bb200×52″ alignment=\u00bbcenter\u00bb css_animation=\u00bbfadeIn\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][block_title style=\u00bbcolumn_title\u00bb inner_style=\u00bbinline_border\u00bb title=\u00bbWednesday July 17 \u00ab][\/block_title][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]CONVENTION HALL<\/strong><\/p>\n

Symposium 1. Molecular Basis of Disease<\/h2>\n

1.1-Novel Molecular Targets for Cancer Therapeutics<\/h3>\n

09:00-09:30<\/strong><\/p>\n

    \n
  • Piero Crespo<\/strong> (Coordinator). Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (CSIC-UC-SODERCAN), Santander, ES<\/li>\n<\/ul>\n

    \u201cRAS subcellular localization as an orchestrator of tumour proliferative vs metastatic potential: an antagonistic tale\u201d<\/em><\/p>\n

    09:30-10:00<\/strong><\/p>\n

      \n
    • David Santamaria. <\/strong>Institut Europ\u00e9en de Chimie et Biologie, INSERM, Bordeaux, FR<\/li>\n<\/ul>\n

      \u201cTargeting quantitative control of MAPK signalling in lung adenocarcinoma\u201d<\/em><\/p>\n

      10:00-10:30<\/strong><\/p>\n

        \n
      • Victoria Sanz-Moreno<\/strong>. Barts Cancer Institute, London, UK<\/li>\n<\/ul>\n

        \u201cNovel roles of ROCK-Myosin II signalling in cancer\u201d<\/em><\/p>\n

        [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_single_image image=\u00bb2054″ img_size=\u00bbfull\u00bb css_animation=\u00bbfadeInLeft\u00bb][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]OSLO-MADRID-VIENA ROOMS<\/strong><\/p>\n

        Symposium 2. Biomolecular Structure and Function<\/h2>\n

        2.1-Eukaryotic SMC complexes<\/h3>\n

        09:00-09:30<\/strong><\/p>\n

          \n
        • Luis Aragon<\/strong> (Coordinator). MRC London Institute of Medical Sciences\/Imperial College London, London, UK<\/li>\n<\/ul>\n

          \u201cSMC-dependent loops on chromosome require chromatin remodelling\u201d<\/em><\/p>\n

          10:00-10:30<\/strong><\/p>\n

            \n
          • Ana Losada<\/strong>. Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid, ES<\/li>\n<\/ul>\n

            \u201cSpecific contributions of variant cohesin complexes to genome folding\u201d<\/em><\/p>\n

            10:00-10:30<\/strong><\/p>\n

              \n
            • Enrique Martinez-Perez<\/strong>. MRC London Institute of Medical Sciences\/Imperial College London, UK.<\/li>\n<\/ul>\n

              \u201cSurveillance of cohesin-mediated chromosome structure regulates meioticprogression\u201d<\/em><\/p>\n

              [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_single_image image=\u00bb2056″ img_size=\u00bbfull\u00bb css_animation=\u00bbfadeInLeft\u00bb][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]BAH\u00cdA-LA PAZ-CARACAS ROOMS<\/strong><\/p>\n

              Symposium 3. Gene Regulation and Cell signalling<\/h2>\n

              3.1-Cell signalling in development and disease<\/h3>\n

              09:00-09:30<\/strong><\/p>\n

                \n
              • Sergio P. Acebr\u00f3n<\/strong> (Coordinator). COS \/ Universit\u00e4t Heidelberg, Heilderberg, DE<\/li>\n<\/ul>\n

                \u201cThe roles of Wnt signalling in mitosis\u201d<\/em><\/p>\n

                09:30-10:00<\/strong><\/p>\n

                  \n
                • Marco Milan<\/strong>. IRB Barcelona, Barcelona, ES<\/li>\n<\/ul>\n

                  \u201cRegulation of anisotropic growth by two orthogonal signalling centres\u201d<\/em><\/p>\n

                  10:00-10:30<\/strong><\/p>\n

                    \n
                  • \u00c1ngela Nieto<\/strong>. Instituto de Neurociencias de Alicante (CSIC-UMH), Alicante, ES<\/li>\n<\/ul>\n

                    \u201cThe complexity of the EMT: beyond cell migration in development and disease\u201d<\/em><\/p>\n

                    [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column][block_title style=\u00bbcolumn_title\u00bb inner_style=\u00bbinline_border\u00bb title=\u00bbThursday July 18 \u00ab][\/block_title][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_single_image image=\u00bb2052″ img_size=\u00bbfull\u00bb css_animation=\u00bbfadeInLeft\u00bb][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]CONVENTION HALL<\/strong><\/p>\n

                    Symposium 1. Molecular Basis of Disease<\/h2>\n

                    1.2-Invertebrate models of human biology<\/h3>\n

                    09:00-09:30<\/strong><\/p>\n

                      \n
                    • Jose Carlos Pastor-Pareja<\/strong> (Coordinator). Tsinghua University, Beijing, CN<\/li>\n<\/ul>\n

                      \u201cBuilding basement membranes: secretion, assembly and fibrotic misassembly\u201d<\/em><\/p>\n

                      09:30-10:00<\/strong><\/p>\n

                        \n
                      • Hector Herranz<\/strong>. University of Copenhagen, Copenhagen, DK<\/li>\n<\/ul>\n

                        \u201cA fly approach to cytokinesis failure and tumorigenesis\u201d<\/em><\/p>\n

                        10:00-10:30<\/strong><\/p>\n

                          \n
                        • Esther Serrano-Saiz<\/strong>. Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM), Madrid, ES<\/li>\n<\/ul>\n

                          \u201cGenetic targets of addiction. From nematodes to vertebrates\u201d<\/em><\/p>\n

                          [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_single_image image=\u00bb2054″ img_size=\u00bbfull\u00bb css_animation=\u00bbfadeInLeft\u00bb][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]OSLO-MADRID-VIENA ROOMS<\/strong><\/p>\n

                          Symposium 2. Biomolecular Structure and Function<\/h2>\n

                          2.2-Recent advances in protein-RNA machineries<\/h3>\n

                          09:00-09:30<\/strong><\/p>\n

                            \n
                          • Guillermo Abascal-Palacios<\/strong> (Coordinator). The Institute of Cancer Research, London, UK<\/li>\n<\/ul>\n

                            \u201cStructural studies of RNA Polymerase III transcription machinery\u201d<\/em><\/p>\n

                            09:30-10:00<\/strong><\/p>\n

                              \n
                            • Carmela Garc\u00eda-Doval<\/strong>. University of Zurich, Zurich, CH<\/li>\n<\/ul>\n

                              \u201cA ring to regulate it all: a CRISPR story\u201d<\/em><\/p>\n

                              10:00-10:30<\/strong><\/p>\n

                                \n
                              • Ana Casa\u00f1al<\/strong>. MRC Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK<\/li>\n<\/ul>\n

                                \u201cTowards a molecular understanding of the eukaryotic mRNA 3\u2019-end processing machinery\u201d<\/em><\/p>\n

                                [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_single_image image=\u00bb1667″ img_size=\u00bbfull\u00bb css_animation=\u00bbfadeInLeft\u00bb][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]BAH\u00cdA-LA PAZ-CARACAS ROOMS<\/strong><\/p>\n

                                Symposium 3. Gene Regulation and Cell Signallling<\/h2>\n

                                3.2-DNA Replication, Repair and Genomic Instability<\/h3>\n

                                09:00-09:30<\/strong><\/p>\n

                                  \n
                                • Emilio Lecona <\/strong>(Coordinator). Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM), Madrid, ES<\/li>\n<\/ul>\n

                                  \u201cRegulation of DNA replication by ubiquitin and SUMO\u201d<\/em><\/p>\n

                                  09:30-10:00<\/strong><\/p>\n

                                    \n
                                  • Andr\u00e9s J. L\u00f3pez-Contreras<\/strong>. Centre for Chromosome Stability, University of Copenhagen, Copenhagen, DK<\/li>\n<\/ul>\n

                                    \u201cProteomics characterization of Chromosomal Common Fragile Sites uncovers ATRX as a regulator of their stability\u201d<\/em><\/p>\n

                                    10:00-10:30<\/strong><\/p>\n

                                      \n
                                    • Julien P. Duxin<\/strong>. Novo Nordisk Foundation Centre for Protein Research, University of Copenhagen, Copenhagen, DK<\/li>\n<\/ul>\n

                                      \u201cMechanisms of DNA-protein crosslink repair\u201d<\/em><\/p>\n

                                      [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column][block_title style=\u00bbcolumn_title\u00bb inner_style=\u00bbinline_border\u00bb title=\u00bbFriday July 19″][\/block_title][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_single_image image=\u00bb2051″ img_size=\u00bbfull\u00bb css_animation=\u00bbfadeInLeft\u00bb][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]CONVENTION HALL<\/strong><\/p>\n

                                      Symposium 1. Molecular Basis of Disease<\/h2>\n

                                      1.3-New insights into the epigenetic regulation of cell fate and disease<\/h3>\n

                                      09:00-09:30<\/strong><\/p>\n

                                        \n
                                      • Lorena Aguilar-Arnal<\/strong> (Coordinator). Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico, MX<\/li>\n<\/ul>\n

                                        \u201cMetabolic control of chromatin dynamics during the circadian cycle\u201d<\/em><\/p>\n

                                        09:30-10:00<\/strong><\/p>\n

                                          \n
                                        • Miguel Angel Esteban<\/strong>. Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, CN<\/li>\n<\/ul>\n

                                          \u201cTranscriptional regulation of pluripotency and reprogramming\u201d<\/em><\/p>\n

                                          10:00-10:30<\/strong><\/p>\n

                                            \n
                                          • M\u00f3nica Lamas<\/strong>. Centro de Investigaci\u00f3n y de Estudios Avanzados, Ciudad de M\u00e9xico, MX<\/li>\n<\/ul>\n

                                            \u201cIs the epigenetic control of the mammalian retinal response to damage preventing regeneration?\u201d<\/em><\/p>\n

                                            [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_single_image image=\u00bb2055″ img_size=\u00bbfull\u00bb css_animation=\u00bbfadeInLeft\u00bb][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]OSLO-MADRID-VIENA ROOMS<\/strong><\/p>\n

                                            Symposium 2. Biomolecular Structure and Function<\/h2>\n

                                            2.3-Structure, function and signal transduction of G-protein coupled receptors<\/h3>\n

                                            09:00-09:30<\/strong><\/p>\n

                                              \n
                                            • Hugo Gutierrez-de-Ter\u00e1n <\/strong>(Coordinator). Uppsala University, Uppsala, SE<\/li>\n<\/ul>\n

                                              \u201cIntegrated approaches to model the effect of protein mutations, the conformational equilibrium and the ligand optimization on GPCRs\u201d<\/em><\/p>\n

                                              09:30-10:00<\/strong><\/p>\n

                                                \n
                                              • Xavier Deup\u00ed<\/strong>. Paul Scherrer Institut, Villigen, CH<\/li>\n<\/ul>\n

                                                \u201cMolecular mechanisms of GPCR-G protein recognition and selectivity\u201d<\/em><\/p>\n

                                                10:00-10:30<\/strong><\/p>\n

                                                  \n
                                                • Martha E. Sommer<\/strong>. Institute for Medical Physics and Biophysics, Charit\u00e9 Medical University, Berlin, DE<\/li>\n<\/ul>\n

                                                  \u201cRevisioning how G protein-coupled receptors activate and bind arrestin\u201d<\/em><\/p>\n

                                                  [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]BAH\u00cdA-LA PAZ-CARACAS ROOMS<\/strong><\/p>\n

                                                  Symposium 3. Gene Regulation and Cell Signallling<\/h2>\n

                                                  3.3-Signalling pathways in Inflammation<\/h3>\n

                                                  09:00-09:30<\/strong><\/p>\n

                                                    \n
                                                  • Ana Cuenda<\/strong> (Coordinator). Centro Nacional de Biotecnolog\u00eda (CSIC), Madrid, ES<\/li>\n<\/ul>\n

                                                    \u201c Alternative p38MAPK, p38\u03b3 and p38\u03b4, in inflammation and cancer\u201d<\/em><\/p>\n

                                                    09:30-10:00<\/strong><\/p>\n

                                                      \n
                                                    • Rudi Beyaert<\/strong>. VIB-UGent Centre for Inflammation Research, Gent, BE<\/li>\n<\/ul>\n

                                                      \u201cRole and therapeutic targeting of MALT1 in inflammation and immunity\u201d<\/em><\/p>\n

                                                      10:00-10:30<\/strong><\/p>\n

                                                        \n
                                                      • Steven C. Ley<\/strong>. Imperial College, London, UK<\/li>\n<\/ul>\n

                                                        \u201cRegulation of inflammation by the TPL-2 complex\u201d<\/em><\/p>\n

                                                        [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

                                                        [vc_row][vc_column width=\u00bb1\/2″][vc_column_text] Symposia Speakers [\/vc_column_text][vc_empty_space][\/vc_column][vc_column width=\u00bb1\/2″][vc_column_text] in collaboration with [\/vc_column_text][vc_single_image image=\u00bb2049″ img_size=\u00bb200×52″ alignment=\u00bbcenter\u00bb css_animation=\u00bbfadeIn\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][block_title style=\u00bbcolumn_title\u00bb inner_style=\u00bbinline_border\u00bb title=\u00bbWednesday July 17 \u00ab][\/block_title][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][\/vc_column][vc_column width=\u00bb3\/4″][vc_column_text css_animation=\u00bbfadeIn\u00bb]CONVENTION HALL Symposium 1. Molecular Basis of Disease 1.1-Novel Molecular Targets for Cancer Therapeutics 09:00-09:30 Piero Crespo (Coordinator). Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (CSIC-UC-SODERCAN), Santander, ES \u201cRAS subcellular localization as an […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1202,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/pages\/1381"}],"collection":[{"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/comments?post=1381"}],"version-history":[{"count":29,"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/pages\/1381\/revisions"}],"predecessor-version":[{"id":2057,"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/pages\/1381\/revisions\/2057"}],"up":[{"embeddable":true,"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/pages\/1202"}],"wp:attachment":[{"href":"https:\/\/congresos.sebbm.es\/madrid2019\/wp-json\/wp\/v2\/media?parent=1381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}